Allotex presented long-term results of presbyopic allogeneic corneal inlay implantation compared between the implanted eye, fellow eye, and changes in binocular visual acuity at the ESCRS iNOVATION DAY on 14 September.

Public source

Publisher name

Public post

Refractive clinics see these patients every day: people with good distance vision, no cataract, and a growing need for near-vision support, yet with few suitable treatme…

Log in to read the full post

Company

Allotex

Natural, tissue-based solutions for refractive surgery

Industry
Medical Device
Location
Boston, US
Company size
11–50 employees

About Allotex

Allotex develops natural, tissue-based solutions for refractive surgery. Precision-shaped collagen implants are designed to integrate naturally with the eye, enabling safe additive procedures that fit seamlessly into modern surgical workflows, with proven clinical outcomes.

See more

Latest activity

6 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.